Viewing nowCombinationRivarohai Tablet 2/160/10 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation

MFDS item code 202502593 · Approved 2025.09.30 · Insurance code 644915470
Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure even with a combination of amlodipine and valsartan and for patients with primary hypercholesterolemia and mixed dyslipidemia. Amlodipine and valsartan effectively lower blood pressure, helping to manage hypertension. Pitavastatin reduces total cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL cholesterol, thus improving blood lipid status. This medication is suitable for patients who need to use both medications together, helping to manage blood pressure and cholesterol simultaneously to improve health.
Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. For patients taking the amlodipine/valsartan combination together with pitavastatin as separate products, switching to this medicine (a combination product containing the same amount of each active ingredient) may be considered for convenience. ▷ Amlodipine/valsartan combination Before starting the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using an individual component as described below, switching directly to the amlodipine/valsartan combination may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. The amlodipine/valsartan combination should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued use.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any component of this medication, severe liver impairment, kidney impairment, specific vascular diseases, or a history of angioedema should not take this medication. Patients with inadequate sodium or fluid levels may experience hypotension; thus, it is essential to check their condition carefully before and during administration. Patients with high potassium levels should be cautious when taking this medication with potassium supplements or other medications that can increase potassium, and regular monitoring of serum potassium levels is necessary. Patients with poor kidney function or renal artery stenosis should undergo periodic kidney function tests as kidney function may worsen during treatment. Patients with heart failure or following myocardial infarction should take this medication cautiously, as cardiac conditions can worsen, following the physician's instructions. This medication may affect liver function; thus, patients with liver impairment should adjust their dosage and undergo regular liver function tests. Muscle pain or weakness may occur, and in severe cases, serious muscle damage known as rhabdomyolysis may develop, necessitating immediate discontinuation and consultation with a physician upon any muscle-related symptoms. Dizziness or fatigue may appear during treatment, so caution is needed when driving or operating machinery. There may be interactions with other medications, especially with potassium-sparing diuretics, cyclosporine, and fibrate drugs, so consultation with a doctor or pharmacist is advised when taking these concurrently. Women who are pregnant or breastfeeding should not take this medication, and breastfeeding should be discontinued if taking this medication. Elderly patients may be more sensitive to this medication, so starting with a lower dose and gradually increasing it is safer. Overdosage can lead to severe hypotension, shock, and heart problems, so strict adherence to the dosing regimen is crucial; if an overdose is suspected, immediate medical attention should be sought. The safety of this medication has not been established in children; therefore, pediatric patients under 18 years of age should not take it. When storing the medication, keep it out of reach of children, and store it in its original container to prevent misuse or deterioration in quality.
COVID-19, nasopharyngitis, systemic edema, peripheral edema, increased blood creatine phosphokinase, headache, itching, sudden hearing loss, intestinal stenosis, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory diminution, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disturbances, nocturia, gynecomastia, pain, fatigue, chest pain, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, serum sickness, increased serum potassium, vascular edema, bullous dermatitis, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, abdominal pain, rash, paralysis, γ-GT elevation, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, rhabdomyolysis, myopathy, liver dysfunction, jaundice, thrombocytopenia, urticaria, rash, erythema, angioedema, elevated bilirubin, increased cholinesterase, rigidity, drowsiness, heavy head, dizziness, dry mouth, abdominal distension, constipation, stomatitis, decreased appetite, glossitis, nausea, gastric discomfort, diarrhea, decreased granulocyte count, leukocytosis, increased globulin, positive Coombs test, anemia, polyuria, increased BUN, decreased aldosterone, increased aldosterone, increased ACTH, increased cortisol, decreased testosterone, muscle cramps, increased serum myoglobin, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, elevated uric acid, increased serum potassium and phosphorus, dysgeusia, discoloration of urine, chronic fatigue, positive ANA, alopecia, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, immune-mediated necrotizing myopathy, facial edema, arm edema, hypersensitivity, skin paresthesia, chest discomfort, elevated blood pressure, asthenia, dizziness, skin paresthesia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored at room temperature between 1 and 30 degrees Celsius, and it is essential to keep it in a sealed container to prevent air exposure. Proper storage helps maintain the medication's effectiveness and prevents degradation.
Pale purple oval film-coated tablet
30 tablets/PVP [6 tablets/PVP x 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.